Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Robertson

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15J D Campbell, G Cook, S E Robertson, et al.
Vaccine|January 18, 2006
Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian FederationA E Platonov, U K Griffiths, M V Voeykova, et al.
The Pediatric Infectious Disease Journal|February 1, 1995
Seroresponse to trivalent oral poliovirus vaccine as a function of dosage intervalA Cohen-Abbo, B S Culley, G W Reed, et al.
The New England Journal of Medicine|September 14, 2000
Trial of a supplemental dose of four poliovirus vaccinesR W Sutter, A J Suleiman, P Malankar, et al.
The New England Journal of Medicine|December 19, 1991
Strategies for the global eradication of poliomyelitis by the year 2000P F Wright, R J Kim-Farley, C A de Quadros, et al.
Bulletin of the World Health Organization|January 1, 1992
Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in KenyaP W Kok, J Leeuwenburg, P Tukei, et al.
Lancet (London, England)|April 23, 1988
Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccineS E Robertson, H P Traverso, J A Drucker, et al.
The Journal of Infectious Diseases|February 1, 1997
Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in OmanR W Sutter, A J Suleiman, P G Malankar, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2001
Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15J D Campbell, G Cook, S E Robertson, et al.
Vaccine|January 18, 2006
Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian FederationA E Platonov, U K Griffiths, M V Voeykova, et al.
The Pediatric Infectious Disease Journal|February 1, 1995
Seroresponse to trivalent oral poliovirus vaccine as a function of dosage intervalA Cohen-Abbo, B S Culley, G W Reed, et al.
The New England Journal of Medicine|September 14, 2000
Trial of a supplemental dose of four poliovirus vaccinesR W Sutter, A J Suleiman, P Malankar, et al.
The New England Journal of Medicine|December 19, 1991
Strategies for the global eradication of poliomyelitis by the year 2000P F Wright, R J Kim-Farley, C A de Quadros, et al.
Bulletin of the World Health Organization|January 1, 1992
Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in KenyaP W Kok, J Leeuwenburg, P Tukei, et al.
Lancet (London, England)|April 23, 1988
Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccineS E Robertson, H P Traverso, J A Drucker, et al.
The Journal of Infectious Diseases|February 1, 1997
Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in OmanR W Sutter, A J Suleiman, P G Malankar, et al.
Pageof 4